Replimune Group, Inc.
REPL
$5.67
$0.071.25%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 92.29M | 74.11M | 64.94M | 60.65M | 59.91M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 292.93M | 259.86M | 239.17M | 229.65M | 234.53M |
| Operating Income | -292.93M | -259.86M | -239.17M | -229.65M | -234.53M |
| Income Before Tax | -279.75M | -246.83M | -227.73M | -212.61M | -219.80M |
| Income Tax Expenses | 468.00K | 468.00K | 510.00K | 408.00K | 207.00K |
| Earnings from Continuing Operations | -280.22 | -247.30 | -228.24 | -213.02 | -220.01 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -280.22M | -247.30M | -228.24M | -213.02M | -220.01M |
| EBIT | -292.93M | -259.86M | -239.17M | -229.65M | -234.53M |
| EBITDA | -287.16M | -253.93M | -233.78M | -224.28M | -229.33M |
| EPS Basic | -3.33 | -3.17 | -3.18 | -3.16 | -3.28 |
| Normalized Basic EPS | -2.08 | -1.98 | -1.99 | -1.97 | -2.05 |
| EPS Diluted | -3.33 | -3.17 | -3.18 | -3.16 | -3.28 |
| Normalized Diluted EPS | -2.08 | -1.98 | -1.99 | -1.97 | -2.05 |
| Average Basic Shares Outstanding | 334.33M | 311.12M | 286.89M | 270.03M | 268.22M |
| Average Diluted Shares Outstanding | 334.33M | 311.12M | 286.89M | 270.03M | 268.22M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |